Oryzon Genomics S.A.
ORYZF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,571 | -$3,353 | -$4,231 | -$7,180 |
| Dep. & Amort. | $148 | $153 | $167 | $144 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,065 | $365 | $1,256 | $2,133 |
| Other Non-Cash | $799 | $2,260 | $961 | $1,276 |
| Operating Cash Flow | -$5,690 | -$575 | -$1,848 | -$3,626 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,710 | $0 | -$76 | -$175 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$102 | -$1 | -$1 | -$6 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $43 |
| Other Inv. Act. | $0 | -$14,503 | -$14,195 | -$11,586 |
| Investing Cash Flow | -$7,811 | -$14,504 | -$14,271 | -$11,724 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $5,374 | $7,901 | $9,642 | $4,123 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$1,800 | -$1,000 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,497 | -$80 | $68 | $0 |
| Financing Cash Flow | $6,871 | $6,021 | $8,710 | $4,123 |
| Forex Effect | -$9 | -$3 | $1 | $348 |
| Net Chg. in Cash | -$6,638 | -$9,060 | -$7,408 | -$10,880 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,257 | $21,317 | $28,725 | $39,605 |
| End Cash | $5,619 | $12,257 | $21,317 | $28,725 |
| Free Cash Flow | -$13,399 | -$15,078 | -$16,118 | -$15,388 |